Kirk, P.S.; Koreckij, T.; Nguyen, H.M.; Brown, L.G.; Snyder, L.A.; Vessella, R.L.; Corey, E.
Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone. Int. J. Mol. Sci. 2013, 14, 10483-10496.
https://doi.org/10.3390/ijms140510483
AMA Style
Kirk PS, Koreckij T, Nguyen HM, Brown LG, Snyder LA, Vessella RL, Corey E.
Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone. International Journal of Molecular Sciences. 2013; 14(5):10483-10496.
https://doi.org/10.3390/ijms140510483
Chicago/Turabian Style
Kirk, Peter S., Theodore Koreckij, Holly M. Nguyen, Lisha G. Brown, Linda A. Snyder, Robert L. Vessella, and Eva Corey.
2013. "Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone" International Journal of Molecular Sciences 14, no. 5: 10483-10496.
https://doi.org/10.3390/ijms140510483
APA Style
Kirk, P. S., Koreckij, T., Nguyen, H. M., Brown, L. G., Snyder, L. A., Vessella, R. L., & Corey, E.
(2013). Inhibition of CCL2 Signaling in Combination with Docetaxel Treatment Has Profound Inhibitory Effects on Prostate Cancer Growth in Bone. International Journal of Molecular Sciences, 14(5), 10483-10496.
https://doi.org/10.3390/ijms140510483